Predicting abnormal coagulation in ischemic stroke: reducing delay in rt-PA use.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 17101901.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Normal prothrombin time (PT) and partial thromboplastin time (PTT) are recommended for administration of recombinant tissue-plasminogen activator (rt-PA) in stroke, but waiting for results can delay use. We examined the charts of 365 stroke patients to assess predetermined risk factors associated with elevated PT/PTT. Elevated PT/PTT can be predicted in patients taking warfarin or heparin/heparinoid or on hemodialysis, according to emergency department triage, with 100% sensitivity and 94.7% specificity. These results could be applied to rt-PA candidates and reduce potential delays.
Medical subject headings
- Brain Ischemia
- Coagulation Protein Disorders
- Stroke
- Tissue Plasminogen Activator